Africa Corporate Wellness Market, by End User, 2018-2027
| Label | Europe | Germany | Spain | France | United Kingdom | Italy | Eastern-Europe | Rest of Western Europe |
|---|---|---|---|---|---|---|---|---|
| 2016 | 791.76 USD Mn | 1632.23 USD Mn | 617.78 USD Mn | 1364.11 USD Mn | 1252.42 USD Mn | 738.05 USD Mn | 1525.46 USD Mn | 332.62 USD Mn |
| 2017 | 884.44 USD Mn | 1818.38 USD Mn | 693.86 USD Mn | 1536.39 USD Mn | 1412.29 USD Mn | 830.60 USD Mn | 1695.74 USD Mn | 373.54 USD Mn |
| 2018 | 986.20 USD Mn | 2021.95 USD Mn | 777.91 USD Mn | 1727.33 USD Mn | 1589.70 USD Mn | 933.09 USD Mn | 1881.52 USD Mn | 418.75 USD Mn |
| 2019 | 1099.66 USD Mn | 2254.06 USD Mn | 871.28 USD Mn | 1942.00 USD Mn | 1789.41 USD Mn | 1048.21 USD Mn | 2087.48 USD Mn | 464.37 USD Mn |
| 2020 | 1226.18 USD Mn | 2512.62 USD Mn | 975.85 USD Mn | 2183.35 USD Mn | 2014.20 USD Mn | 1177.55 USD Mn | 2315.81 USD Mn | 514.95 USD Mn |
| 2021 | 1367.26 USD Mn | 2800.61 USD Mn | 1092.98 USD Mn | 2454.70 USD Mn | 2267.24 USD Mn | 1322.84 USD Mn | 2568.89 USD Mn | 571.04 USD Mn |
| 2022 | 1524.58 USD Mn | 3121.37 USD Mn | 1224.16 USD Mn | 2759.77 USD Mn | 2552.06 USD Mn | 1486.05 USD Mn | 2849.40 USD Mn | 633.24 USD Mn |
| 2023 | 1699.99 USD Mn | 3478.57 USD Mn | 1371.08 USD Mn | 3102.75 USD Mn | 2872.66 USD Mn | 1669.40 USD Mn | 3160.27 USD Mn | 702.22 USD Mn |
| 2024 | 1895.58 USD Mn | 3876.34 USD Mn | 1535.64 USD Mn | 3488.36 USD Mn | 3233.53 USD Mn | 1875.38 USD Mn | 3504.76 USD Mn | 778.71 USD Mn |
Data Source: Wantstats Repository
Market Dynamics
Germany accounted for the largest market share in 2017 in the Europe chemotherapy market, and is expected to reach USD 3876.34 Million in 2024 from USD 1818.38 Million in 2017. However, United Kingdom is the fastest growing market, which is expected to grow at a CAGR of 12.56% during the forecast period 2018 - 2024. alkylating agents segment accounted for the largest market share in 2017, this market is expected to reach USD 6625.44 Million in 2024 from USD 2996.00 Million in 2017. This market is projected to grow at a CAGR of 12.09% during the forecast period from 2018 - 2024. However, alkylating agents segment is the fastest growing market, which is expected to grow at a CAGR of 12.09% during the forecast period 2018 - 2024. speciality centers segment accounted for the largest market share in 2017, this market is expected to reach USD 10499.41 Million in 2024 from USD 4716.33 Million in 2017. This market is projected to grow at a CAGR of 12.11% during the forecast period from 2018 - 2024.
However, speciality centers segment is the fastest growing market, which is expected to grow at a CAGR of 12.11% during the forecast period 2018 - 2024. intravenous segment accounted for the largest market share in 2017, this market is expected to reach USD 8398.07 Million in 2024 from USD 3942.63 Million in 2017. This market is projected to grow at a CAGR of 11.41% during the forecast period from 2018 - 2024. However, oral segment is the fastest growing market, which is expected to grow at a CAGR of 12.28% during the forecast period 2018 - 2024. indication others segment accounted for the largest market share in 2017, this market is expected to reach USD 6677.97 Million in 2024 from USD 3152.32 Million in 2017. This market is projected to grow at a CAGR of 11.32% during the forecast period from 2018 - 2024. However, breast cancer segment is the fastest growing market, which is expected to grow at a CAGR of 12.27% during the forecast period 2018 - 2024.
Research Methodology
Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2023.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



